Skip to main content

ADC Therapeutics SA 8-K, filed Nov 9, 2026

ADC Therapeutics SA (ADCT)

8-K 2026-11-09 For: 2026-11-09
View Original
Added on November 09, 2026

About this 8-K

ADC Therapeutics SA filed this 8-K on November 9, 2026.

ADC Therapeutics reported third-quarter net product revenue of $21.0 million and net loss of $25.3 million. Its October 2026 restructuring included an $86.6 million PIPE and extends expected cash runway into 2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits